This podcast has been supported by Novartis.
Please refer to the latest local Prescribing Information applicable in your country.
In this short video from the European Hematology Association (EHA) Congress 2026, held between 11th–14th June, 2026, in Stockholm, Sweden, Koji Sasaki discussed key updates in Chronic Myeloid Leukemia (CML) and looked towards the future of CML care.
Topics include:
- The progress made in CML
- The Week 144 ASC4FIRST trial data
- Quality of life for patients with CML
- The potential uses of digital tools and AI
Speaker
Koji Sasaki1
1. Institute of Science Tokyo, Japan
